Fasken advised BioTwin in connection with this transaction. On April 8, 2021, BioTwin, a Quebec-based biotechnology company, announced the completion of their pre-seed funding round. The...
Fasken advised BioTwin in connection with this transaction. On April 8, 2021, BioTwin, a Quebec-based biotechnology company, announced the completion of their pre-seed funding round. The...
You must be a Standard 1 Year member to access this content.